We deliver fully integrated, regulatory-aligned turnkey design and construction solutions for cGMP-compliant biopharmaceutical manufacturing facilities, covering greenfield new-build developments and brownfield upgrading, expansion and retrofitting projects. Encompassing process-driven master planning, classified cleanroom engineering, specialty utility system implementation, full-process equipment integration, intelligent automation deployment and complete validation enablement, our one-stop delivery model unifies all disciplines under a single point of accountability. Tailored for monoclonal antibodies, recombinant proteins, mRNA vaccines, viral vectors, sterile injectables and veterinary biologics, our solutions eliminate traditional fragmented multi-vendor gaps, reduce project risks, and build inspection-ready manufacturing infrastructure that supports clinical progression, global regulatory filing and stable commercial-scale production.
Our practice is anchored in risk-based process design, compliant modular construction and future-proof operational scalability. We embed ICH QbD principles, contamination control strategies and data integrity architecture into the earliest design stages, ensuring facility layout, personnel and material flow, pressure cascade zoning and utility distribution fully align with biomanufacturing process logic. By adopting parallelized engineering workflows, standardized sanitary frameworks and modular prefabrication methodologies, we balance accelerated project delivery, stringent aseptic safety requirements and long-term batch-to-batch production consistency, delivering robust plant architecture adaptable for multi-product campaign switching and phased capacity expansion.
All design criteria, construction specifications and system configurations fully comply with FDA, EMA Annex 1, PIC/S, ICH and ISPE international biopharmaceutical standards. Every cleanroom classification, sanitary piping detail, utility purity parameter and automated control function is engineered to meet strict bioburden, particulate, endotoxin and cross-contamination control requirements. Equipped with 21 CFR Part 11 compliant monitoring and MES data traceability systems, our facilities maintain full lifecycle audit readiness, supporting global GMP certification, routine authority inspections and cross-border product registration for high-end biologic and sterile drug pipelines.
We provide end-to-end lifecycle services from preliminary feasibility study and regulatory gap analysis, detailed architectural & process engineering, on-site construction management and equipment integration, to commissioning, qualification and post-handover technical support. Our unified project execution system minimizes design rework, shortens overall project timelines and standardizes quality output across all project phases. With validated, operationally efficient and regulatory-resilient plant assets, clients achieve faster time-to-market, lower operational costs and sustainable manufacturing competitiveness in the global biopharmaceutical industry.
